Horizon Technology Finance Management

Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

Finexio operates a payment platform that streamlines accounts payable processes for medium and large corporations. By leveraging a unique network of closed loop systems, Finexio eliminates the need for paper checks, allowing businesses to identify suppliers that can be paid electronically. The platform facilitates direct transfers to suppliers' bank accounts without requiring sensitive bank account information, thereby reducing transaction costs associated with traditional payment methods. Finexio integrates with various payment aggregators, accounts payable automation, and procurement software, providing a more efficient payment solution that significantly lowers fees compared to standard commercial payment costs.

Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.

GT Medical Technologies, Inc. is a medical device company based in Tempe, Arizona, dedicated to improving the lives of patients with brain tumors. Founded in 2017, the company has developed an innovative treatment approach through its flagship product, GammaTile, which combines a biocompatible, conformable collagen matrix with brachytherapy radiation seeds. This technology is designed to address the limitations of existing treatments for recurrent brain tumors, providing a bioresorbable solution that enhances treatment efficacy. GammaTile is protected by multiple patents and has the potential to benefit a significant patient population, with an estimated 176,000 patients diagnosed annually in the United States. To date, clinical trials at Barrow Neurological Institute have demonstrated promising outcomes, with significant clinical improvements observed in patients treated with this novel device.

Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Mirantis, Inc. is a technology company that specializes in providing software, services, and training for open source cloud environments. It offers a range of solutions including OpenStack distribution software, cloud-ready application tools like Murano, and Containers-as-a-Service for developers and operators. The company empowers organizations to build and manage open cloud infrastructure, facilitating a public cloud experience across various infrastructures while eliminating vendor lock-in. Mirantis also provides infrastructure solutions that support virtualization, application deployment, and cloud management, enabling seamless development and operations. Its portfolio includes training programs for DevOps professionals and managed services for implementation and migration. Founded in 1993 and headquartered in Campbell, California, Mirantis has expanded its presence internationally, with offices in Russia, France, Poland, and Ukraine.

Elligo Health Research, Inc. is a healthcare organization focused on enhancing clinical research through innovative infrastructure and technology. Founded in 2016 and headquartered in Austin, Texas, the company facilitates the integration of clinical research into healthcare clinics, enabling faster development of pharmaceutical, biotechnology, and medical device products. By utilizing advanced health informatics and electronic health records, Elligo helps identify suitable patients for clinical trials and offers physicians the necessary support to conduct trials efficiently without the need for significant infrastructure investments. This approach not only accelerates patient enrollment and trial completion for sponsors but also allows patients to participate in clinical research within their own healthcare settings, minimizing logistical challenges and contributing to advancements in medical care. Additionally, Elligo empowers physicians with knowledge of emerging therapies, ultimately enhancing patient care and engagement in the research process.

Sonex Health, LLC, founded in 2014 and based in Rochester, Minnesota, specializes in developing micro-invasive surgical devices aimed at enhancing patient care and reducing healthcare costs. The company is known for its SX-One MicroKnife featuring Meerkat Technology, which enables a novel approach to treating carpal tunnel syndrome through an ultrasound-guided carpal tunnel release procedure. This innovative technique allows surgeries to be performed in outpatient settings rather than operating rooms, facilitating quicker patient recovery and improved cosmetic outcomes. The SX-One MicroKnife utilizes a micro-incision significantly smaller than traditional methods, often requiring only a small adhesive bandage for closure. This results in a low-trauma surgical experience that allows patients to begin rehabilitation immediately, minimizing downtime and promoting a swift return to daily activities. Sonex Health is dedicated to refining surgical practices to address important healthcare challenges effectively.

Tallac Therapeutics is a biopharmaceutical company based in Burlingame, California, focused on developing innovative immunotherapies for cancer patients. Established in 2018, the company specializes in creating conjugates of antibodies combined with potent toll-like receptor agonists. This approach aims to activate the immune system in a targeted manner, enhancing both innate and adaptive immunity to effectively combat various solid tumor malignancies. By providing advanced treatment options, Tallac Therapeutics seeks to improve patient outcomes in the fight against cancer.

Viken Detection Corporation, founded in 2013 and headquartered in Newton, Massachusetts, specializes in the development and marketing of handheld X-ray instruments. The company offers a range of devices, including the Pb200i handheld XRF lead paint analyzer, which is utilized for various applications such as lead-based paint testing, environmental assessments, and materials compliance for hazardous substances. Viken Detection's technology also plays a critical role in security imaging and material identification, assisting law enforcement and safety inspection agencies in detecting concealed threats in vehicles and other locations, thereby enhancing public safety. In addition to its product offerings, the company provides leasing and financing services to accommodate businesses of all sizes. Viken Detection was formerly known as Heuresis Corporation, reflecting its evolution in the field of X-ray physics and analytical device design.

SafelyYou, Inc. is a technology company based in Berkeley, California, founded in 2015, that specializes in artificial intelligence software designed for managed Alzheimer's care. The company focuses on fall prevention by utilizing a camera system installed in patients' rooms to detect falls in real time and alert caregivers. Its AI-enabled technology analyzes patterns and signs that may indicate a potential fall, allowing for proactive intervention. SafelyYou's solutions aim to enhance the safety and well-being of individuals with Alzheimer's and other forms of dementia, facilitating improved medication adherence, behavioral monitoring, and overall care management in skilled nursing facilities and assisted living communities. By reducing the frequency and impact of falls, SafelyYou contributes to lowering hospitalization rates among this vulnerable population.

Unagi Scooters is an electric scooter startup focused on providing an eco-friendly transportation solution for urban commuters. The company designs high-performance electric scooters that are capable of traveling long distances on a single charge and can navigate hilly terrains smoothly. By offering a convenient and efficient mode of transport, Unagi aims to alleviate common transportation challenges, such as high costs and carbon emissions, while enhancing the overall commuting experience.

Evelo Biosciences is a biotechnology company focused on discovering and developing oral biologics known as monoclonal microbials for the treatment of inflammatory diseases and cancer. These innovative medicines are designed to modulate systemic immunology through direct interactions with human cells in the gut, offering potential applications across a wide range of conditions, including autoimmune and neuroinflammatory diseases, as well as various cancers. Evelo's lead product, EDP1815, is currently undergoing clinical trials for psoriasis and atopic dermatitis, while other candidates are in preclinical stages for conditions such as psoriatic arthritis, asthma, and colorectal cancer. Founded in 2014 and based in Cambridge, Massachusetts, Evelo aims to enhance the efficiency and effectiveness of drug discovery by leveraging naturally occurring microbial entities with defined therapeutic effects.

Slingshot Aerospace, Inc. is a technology company that develops online tools and platforms to provide geospatial information for the aerospace and defense industries. With its suite of platforms, including Slingshot Earth, Slingshot Orbital, Slingshot Edge, and Slingshot Imagery, the company integrates data streams from various sources, such as satellites, drones, and ground-based sensors, to deliver critical insights that enhance decision-making for its clients. Operating from its headquarters in El Segundo, California, and an additional office in Austin, Texas, Slingshot Aerospace serves a diverse range of sectors, including energy, aerospace, insurance, military, government, engineering services, and emergency management. The company's mission is to empower both government and commercial space organizations by providing simulation and analytics solutions that improve mission success and ensure safe, reliable operations in complex environments.

Robin Healthcare, Inc. is a healthcare technology company that focuses on enhancing the medical industry through innovative software solutions. Founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas, the company provides a range of services including clinical documentation solutions, medical scribe services, order and medication entry, chart review, billing and coding, and referral management. By integrating technology with trained medical scribes, Robin Healthcare aims to streamline administrative tasks and improve the doctor-patient experience, allowing healthcare professionals to dedicate more time to patient care while maintaining control over their practices.

Kodiak Robotics, Inc. is focused on developing autonomous technology specifically for long-haul trucking. Founded in 2018 and based in Mountain View, California, the company specializes in creating self-driving trucks designed to operate on highway routes. Kodiak Robotics employs advanced sensor fusion systems and innovative mapping solutions to enable its vehicles to manage all aspects of highway driving. This technology aims to enhance network efficiency and reduce operational costs for businesses in the logistics sector.

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company based in North Brunswick, New Jersey, focused on developing immunotherapies for cancer and infectious diseases. Founded in 2005, the company aims to prevent and treat various cancers, including cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, and vulvar cancers. PDS Biotechnology's product pipeline includes PDS0101, a treatment for HPV-related cancers; PDS0102, a pandemic influenza vaccine; and PDS0103, a series of immunotherapy products for non-viral cancers. The company's proprietary Versamune platform technology is designed to activate and direct the human immune system to effectively target and attack cancer cells, supporting its commitment to innovative cancer treatment solutions.

Nexii is a green construction technology company focused on creating sustainable and resilient buildings. By designing and manufacturing high-performance building solutions, Nexii aims to transform the construction industry to prioritize health, affordability, and sustainability. The company’s innovative approach significantly reduces construction timelines and costs, allowing clients to benefit from faster and more efficient building processes. Nexii's commitment to sustainability and resilience addresses the challenges posed by climate change, making its products a viable choice for modern construction needs.

Inbrace is a medical device company focused on innovative orthodontic solutions. Its flagship product, INBRACE, is a discreet alignment system that is placed behind the teeth, utilizing patented self-guiding technology to apply continuous forces for gentle correction of dental alignment. This approach significantly reduces pain and minimizes the number of required visits to the orthodontist, addressing common patient concerns and enhancing satisfaction. INBRACE is FDA registered and aims to expand access to orthodontic treatment, thereby driving practice growth for dental professionals. The company's platform incorporates digital treatment planning, computer modeling, and direct digital manufacturing, allowing for customized solutions that maintain high standards of care across various orthodontic cases.

Divergent Technologies, Inc. is a Los Angeles-based company that specializes in the development and manufacturing of 3D printed vehicles. Incorporated in 2014, Divergent has pioneered the Divergent Adaptive Production System (DAPS™), an innovative software-hardware platform designed to revolutionize industrial digital manufacturing. This system enables customers to design, additively manufacture, and automatically assemble complex structures for a variety of applications, including automotive, aerospace, and defense. By optimizing designs and dematerializing structures, DAPS significantly enhances manufacturing efficiency while reducing waste and environmental impact. The company's approach eliminates the need for traditional tooling, facilitating radical innovation and capital reduction in vehicle manufacturing.

Soli Organic is an indoor farming startup specializing in the cultivation and distribution of fresh organic culinary herbs. The company supplies grocery stores with a year-round availability of various herbs, including basil, lime leaves, rosemary, chives, and arugula. By providing living organic plants with fresh-cut leaves, Soli Organic aims to enhance the flavor of meals while promoting healthy eating. Their commitment to regional growth allows consumers to enjoy locally sourced herbs throughout the year, contributing to a more flavorful and sustainable food experience.

Secure Transfusion Services is a life sciences company that aims to improve the quality and availability of transfusable blood components. The company is dedicated to helping the blood industry modernize and stabilize by enhancing the vital role that nonprofit blood banks play in ensuring the nation's blood supply.

Aerobiotix is a privately held company focused on developing and manufacturing proprietary environmental management devices. Its products are designed for use in institutional healthcare, home health, and commercial settings. The company provides a range of innovative technologies that effectively eliminate airborne viruses, bacteria, and spores, thereby enhancing indoor air quality and optimizing the overall environment.

Interior Define Inc. is a furniture design and manufacturing company founded in 2013 and based in Chicago, Illinois. It specializes in offering a range of customizable furniture products, including sofas, chairs, beds, and dining pieces. The company employs a made-to-order production approach, allowing customers to personalize their furniture in various aspects such as size, fabric, configuration, and leg style. This model minimizes inventory costs, enabling Interior Define to provide high-quality custom furniture at accessible prices. Customers can explore their options online through a 360-degree viewing experience and order free fabric swatches. Additionally, the company offers an augmented reality app to visualize furniture in their homes. Interior Define also operates Guideshop locations in several major cities, where customers can experience the products firsthand and receive personalized consultations from expert staff. The company is known for its customer-centric services, including complimentary white glove delivery and a standard 365-day return policy, enhancing the overall shopping experience.

IMV Inc. is a clinical-stage biopharmaceutical company based in Dartmouth, Canada, focused on developing innovative cancer immunotherapies and vaccines for infectious diseases. The company utilizes its patented DepoVax platform to enhance immune responses, allowing for controlled and prolonged exposure of antigens. Its lead candidate, DPX-Survivac, is a targeted T cell therapy that has shown promising results in multiple Phase 1 and 1b trials for late-stage ovarian cancer and relapsed/refractory diffuse large B cell lymphoma (DLBCL). IMV is currently conducting Phase 2 trials for DPX-Survivac across several cancer indications and exploring its use in combination with Merck's Keytruda. Additionally, IMV is developing a DPX-based vaccine candidate against COVID-19 and a vaccine targeting the respiratory syncytial virus. The company also has a diverse pipeline of vaccine candidates for various infectious diseases, including malaria and anthrax, and maintains partnerships in the animal health sector.

Everstream Analytics is a supply chain risk analytics company focused on enhancing the resilience and agility of clients' supply chains. By integrating with procurement, logistics, and business continuity platforms, the company provides comprehensive global visibility of supply chain risks. Utilizing data science, proprietary intelligence, and a team of multilingual specialists, Everstream Analytics monitors global risks and events in real-time, allowing clients to respond proactively. Its platform tracks risk alongside business performance indicators, builds detailed risk profiles, and identifies critical hotspots through heat maps. This approach enables businesses to effectively visualize and manage potential disruptions, ensuring continuity and transforming risks into competitive advantages.

Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of therapies targeting diseases linked to mitochondrial dysfunction. Founded in 2006 and based in George Town, Cayman Islands, the company is advancing its lead product candidate, Elamipretide, which aims to address both rare genetic and age-related mitochondrial diseases. Additionally, Stealth BioTherapeutics is developing SBT-20, a small peptide that stabilizes mitochondrial structure and function during oxidative stress, and SBT-272, a compound under evaluation for rare neurodegenerative diseases, including amyotrophic lateral sclerosis. Mitochondria play a crucial role in energy production and overall organ function, making the company's focus on these organelles significant in the biopharmaceutical landscape.

Nogin is an intelligent commerce platform that enables leading brands to keep pace with big retail, drive predictable profitability, and exponential growth, and grow rapidly into the future of commerce. Brands selling direct to consumers (D2C) and through online channel partners can use the Nogin Intelligent Commerce technology, a cloud-based e-commerce environment. Customers of Nogin are free to manage as much or as little of the infrastructure as they see fit while concentrating on their brands.

Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, dedicated to developing and commercializing implantable medical devices aimed at soft tissue restoration and regeneration. Founded in 2014, the company specializes in biomaterial design and bio-fabrication, focusing on collagen-based microfibers for tendon and ligament repair. Its innovative products are designed to meet the needs of warfighters, athletes, and individuals with sports injuries, utilizing a precision medicine approach to replicate the biological and biomechanical properties of native tissue. The goal of Embody is to enhance the quality of life for patients by restoring their pre-injury performance through effective healing solutions.

Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, dedicated to developing and commercializing implantable medical devices aimed at soft tissue restoration and regeneration. Founded in 2014, the company specializes in biomaterial design and bio-fabrication, focusing on collagen-based microfibers for tendon and ligament repair. Its innovative products are designed to meet the needs of warfighters, athletes, and individuals with sports injuries, utilizing a precision medicine approach to replicate the biological and biomechanical properties of native tissue. The goal of Embody is to enhance the quality of life for patients by restoring their pre-injury performance through effective healing solutions.

Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases. Founded in 2011 and headquartered in Rockville, Maryland, the company is advancing a clinical-stage pipeline that includes therapies for inherited metabolic disorders, such as CERC-801, CERC-802, and CERC-803, which are focused on congenital disorders of glycosylation. Additionally, Cerecor is developing CERC-006, an oral mTOR inhibitor aimed at treating complex lymphatic malformations, and two monoclonal antibodies: CERC-002, targeting the cytokine LIGHT for severe pediatric-onset Crohn's disease, and CERC-007, targeting IL-18 for autoimmune inflammatory diseases like adult onset Still's disease and multiple myeloma. Several of these therapies have received Orphan Drug Designation and Rare Pediatric Disease Designation, qualifying them for expedited review upon FDA approval. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions.

RepTrak is the creator of an enterprise software platform and subscription-based service that helps businesses understand, improve, and protect their corporate reputation through key data analytics. Its proprietary RepTrak model is the global standard for measuring and analyzing global sentiment across industries and geographies, using proven data science models and machine learning techniques. The RepTrak Company, founded in 2004, owns a large reputation benchmarking database of over 1 million company ratings per year, which is used by CEOs, boards, and executives in over 60 countries worldwide.

LiquiGlide Inc., founded in 2012 and headquartered in Cambridge, Massachusetts, specializes in developing custom-designed liquid-impregnated coatings that create permanently wet slippery surfaces. This innovative technology enables viscous liquids to slide effortlessly, providing a unique and durable solution not available from other companies. LiquiGlide's products cater to a wide range of industries, including manufacturing, oil and gas, processing, aviation, utilities, power generation, water treatment, chemicals, and medical sectors, as well as food and beverage, health and beauty, and household products. The company aims to improve efficiency and reduce waste across various applications by enhancing the flow of liquids.

Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases. Founded in 2011 and headquartered in Rockville, Maryland, the company is advancing a clinical-stage pipeline that includes therapies for inherited metabolic disorders, such as CERC-801, CERC-802, and CERC-803, which are focused on congenital disorders of glycosylation. Additionally, Cerecor is developing CERC-006, an oral mTOR inhibitor aimed at treating complex lymphatic malformations, and two monoclonal antibodies: CERC-002, targeting the cytokine LIGHT for severe pediatric-onset Crohn's disease, and CERC-007, targeting IL-18 for autoimmune inflammatory diseases like adult onset Still's disease and multiple myeloma. Several of these therapies have received Orphan Drug Designation and Rare Pediatric Disease Designation, qualifying them for expedited review upon FDA approval. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions.

Launched in 2016, Fingerlix is the brainchild of 4 foodies. Their purpose is to spread Joy through food by easing up cooking and exploration. They believe that Joy stems from spending more time with family and less time in the kitchen. Joy is maximum when they discover something new and different that entices their taste buds. Joy also comes from making healthier, happier food choices that leave us with a feeling of goodness. Through their Ready-to-Cook & Ready-to-Eat food options, they want to be a part of your cooking journey, partnering you, everyday - day after day. And they do their best to make that happen – sourcing choicest ingredients, maintaining extremely high hygiene standards and above all, inspiring your magical touch to transform every dish into ‘Your dish’.

Alula Holdings, LLC is a smart security company headquartered in Hudson, Wisconsin, that specializes in developing an integrated security platform for security dealers and installers. Founded in 2018, the company offers a comprehensive solution that encompasses security, alarm, video, and automation services tailored for renters, homeowners, and commercial installations. Alula's platform is designed to simplify security for independent dealers and their customers, providing low-cost, Internet-based interactive alarm systems and connected property products. By delivering differentiated security and automation solutions, Alula enables professional alarm dealers and integrators to enhance their business profitability while offering a consistent management experience. The company focuses on empowering its partners with technology-rich solutions that showcase their brand effectively.

IDbyDNA, Inc. is a company specializing in metagenomics technologies aimed at identifying infectious diseases. Founded in 2014 and based in Salt Lake City, Utah, it has developed a platform called Explify, which enables laboratories to detect and characterize pathogens using nucleic acid-based techniques. The company offers comprehensive testing services, including respiratory and research services, catering to hospitals, reference labs, clinical research institutions, and the biopharmaceutical sector. By leveraging computational biology and artificial intelligence, IDbyDNA strives to enhance diagnostic accuracy and treatment precision for infectious diseases, addressing the growing global challenge posed by these conditions.

Corinth MedTech, Inc. is a medical device company based in Cupertino, California, specializing in the manufacture of disposable bipolar transurethral and transcervical resectoscopes. Founded in 2011, the company has developed systems for endoscopically controlled tissue removal for male patients with benign prostatic hyperplasia (BPH) and for female patients with conditions such as abnormal uterine bleeding, fibroids, and polyps requiring hysteroscopic intervention. Corinth MedTech's proprietary technology enables medical professionals to perform precise resection and coagulation of prostate adenomas and bladder tumors, facilitating effective treatment under continuous flow conditions. The company aims to enhance patient outcomes through its innovative medical solutions.

Sonex Health, LLC, founded in 2014 and based in Rochester, Minnesota, specializes in developing micro-invasive surgical devices aimed at enhancing patient care and reducing healthcare costs. The company is known for its SX-One MicroKnife featuring Meerkat Technology, which enables a novel approach to treating carpal tunnel syndrome through an ultrasound-guided carpal tunnel release procedure. This innovative technique allows surgeries to be performed in outpatient settings rather than operating rooms, facilitating quicker patient recovery and improved cosmetic outcomes. The SX-One MicroKnife utilizes a micro-incision significantly smaller than traditional methods, often requiring only a small adhesive bandage for closure. This results in a low-trauma surgical experience that allows patients to begin rehabilitation immediately, minimizing downtime and promoting a swift return to daily activities. Sonex Health is dedicated to refining surgical practices to address important healthcare challenges effectively.

Getaround, Inc. is an online marketplace specializing in peer-to-peer car sharing and local car rentals. Founded in 2009 and based in San Francisco, California, Getaround allows users to rent vehicles on-demand, ranging from economy cars to luxury models, by the hour or day. The platform facilitates a seamless experience through its patented Getaround Connect technology, which enables users to access cars without needing to meet the vehicle owner or handle physical keys. This innovative approach eliminates the traditional hassles of car rental, such as long lines and paperwork. Getaround operates in several major U.S. cities, including San Francisco, San Diego, Chicago, and Washington, D.C., providing a convenient and eco-friendly alternative to car ownership while allowing vehicle owners to earn extra income. The service also includes comprehensive insurance and 24/7 roadside assistance, ensuring a safe and enjoyable experience for users.

Topia Limited is a provider of mobility management solutions that focuses on global talent mobility for businesses. Established in 2010 and headquartered in London, with an additional office in San Francisco, Topia offers a comprehensive platform that streamlines the entire talent mobility process. This includes relocation and expatriate administration, tax and immigration management, and payroll calculations. The company’s platform, known as Topia One, is a cloud-based system that integrates data standards across global talent mobility. Additionally, the Topia Go mobile application allows employees to manage their relocations and assignments effectively. Topia serves a diverse clientele, including well-known brands such as Dell, Schneider Electric, and Deliveroo, and has established strategic partnerships with organizations like Fragomen Worldwide and the Employee Mobility Institute. The company was previously known as MOVE Guides Limited until its rebranding in April 2018.

Emalex Biosciences is a biotechnology startup focused on developing innovative treatments for central nervous system (CNS) disorders and rare neurological conditions. Founded in 2018 by Jeff Aronin, the company is advancing its lead candidate, Ecopipam, which has been explored as a potential therapy for various CNS disorders, including pediatric Tourette Syndrome and fluency disorders. Emalex aims to address the needs of patients with rare diseases that currently have limited or no treatment options, collaborating with patient advocacy organizations and medical researchers to facilitate the development of effective biopharmaceutical therapies.

Magnolia Medical Technologies, Inc. is a medical device company based in Seattle, Washington, focused on enhancing the accuracy of diagnostic blood culture tests. Established in 2011, the company has developed SteriPath, a vacuum-assisted blood collection system designed to prevent contamination of blood samples, which can lead to misdiagnosis of sepsis. This innovative system operates by actively diverting and sequestering contaminated blood, allowing for the collection of uncontaminated samples through a separate flow path. This closed vein-to-bottle collection method aims to improve diagnostic specimen quality, thereby increasing diagnostic accuracy and improving patient outcomes. Magnolia Medical Technologies holds a robust intellectual property portfolio, including over 70 issued patents and more than 50 pending applications, reflecting its commitment to advancing medical technology and addressing challenges such as antibiotic resistance. The company's products are distributed throughout the United States.

Ceribell, Inc. is a medical technology company that designs and manufactures devices for electroencephalography (EEG) data acquisition and interpretation, aimed at improving the diagnosis and management of neurological conditions. Its flagship product, the Ceribell EEG System, includes a flexible EEG Headband that accommodates various hair types and head sizes, alongside a portable EEG Recorder that ensures clinical-quality data and on-device display. The system is designed to be set up by any healthcare provider within six minutes, making EEG testing more accessible and efficient. Notably, it features a unique function that converts brainwaves into sound, allowing for quicker detection of seizures without the need for specialized technicians. This innovation facilitates earlier diagnosis and targeted treatment for patients, particularly for non-convulsive seizures, thereby reducing the risk of complications and improving overall patient outcomes. Established in 2014 and based in Mountain View, California, Ceribell is committed to enhancing care in hospital ICUs, inpatient units, and emergency departments.

Castle Creek Biosciences, Inc. is a gene therapy company headquartered in Exton, Pennsylvania, that specializes in developing and commercializing personalized gene therapies for rare skin and connective tissue disorders. Founded in 2015, the company utilizes a fibroblast technology platform that extracts fibroblast cells from a patient's own skin to create localized therapies tailored to the individual’s unique biology. This innovative approach aims to address the underlying causes of diseases that currently have high unmet medical needs, ultimately improving the lives of patients suffering from these underserved conditions.

OutboundEngine, Inc. is a marketing technology company based in Austin, Texas, that specializes in providing marketing automation solutions for small and midsize businesses across various sectors, including real estate, finance, insurance, and wellness. Founded in 2010, the company offers a cloud-based platform that simplifies online marketing by automating email campaigns, social media postings, and online review collection. This platform, known as The OutboundEngine Platform, enables clients to deliver personalized marketing content efficiently and effectively. In addition to its core offerings, OutboundEngine provides a tool called Harmony, which facilitates unified marketing across franchise and agent networks. The company has established itself as a leader in the marketing automation space, serving over 10,000 customers and earning recognition as a top workplace in Austin.

Meditrina, Inc. is a medical device company based in San Jose, California, specializing in tissue removal solutions for intrauterine pathology. Founded in 2016, the company has developed the Aveta System, an all-in-one solution designed for hysteroscopic diagnostic and therapeutic procedures. This system enables healthcare professionals to perform tasks such as the removal of polyps and fibroids in both office and operating room settings. The Aveta System features wide-angle HD hysteroscopy with electronic image-lock, advanced fluid management for better pressure and fluid control, and a compact design that allows for seamless integration into various medical environments. By providing advanced, convenient, and cost-effective options, Meditrina aims to enhance the care experience for both patients and physicians.

Encore Dermatology is a privately held, fully-integrated dermatology company based in Malvern, Pennsylvania, established in 2015. The company specializes in delivering prescription therapies and medical devices to dermatologists, focusing on a variety of medical dermatology products. These offerings address several topical disease states, including conditions like acne and atopic dermatitis, thereby facilitating enhanced skincare and treatment options for patients. Through its comprehensive approach, Encore Dermatology aims to improve patient outcomes and streamline the dermatological care process.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative cell and gene therapies aimed at treating hematologic cancers, solid tumors, and rare genetic diseases. The company has a diverse pipeline that includes gene therapy programs for rare genetic disorders and various chimeric antigen receptor (CAR) T cell therapies targeting both hematologic malignancies and solid tumors. Notable projects include MB-107, a gene therapy aimed at treating X-linked severe combined immunodeficiency, which is currently undergoing Phase 1/2 clinical trials. Other therapies under development include MB-102 for acute myeloid leukemia, MB-106 for B-cell lymphomas, and multiple CAR T programs targeting glioblastoma, prostate cancer, and pancreatic cancer. Mustang Bio also collaborates with institutions such as Nationwide Children’s Hospital and Beth Israel Deaconess Medical Center for research and development in gene editing and oncolytic viruses. Established in 2015 and headquartered in New York, Mustang Bio operates as a subsidiary of Fortress Biotech, Inc.

CSA Medical, Inc. specializes in the development and manufacturing of spray cryotherapy medical devices. The company's flagship product, the truFreeze device, utilizes cold liquid nitrogen as a cryosurgical tool for the destruction of unwanted tissue in dermatology, gynecology, and general surgery, while facilitating the regrowth of healthy tissue. Additionally, CSA Medical offers the Rapid AV Spray Kit, which enhances the truFreeze system by reducing the time required for liquid nitrogen application. Originally founded as Crymed Technologies in 1993, the company rebranded to CSA Medical in April 2006. Headquartered in Lutherville Timonium, Maryland, CSA Medical also operates a research and development facility in Lexington, Massachusetts.

MacuLogix, Inc. specializes in the diagnosis, monitoring, and treatment of age-related macular degeneration (AMD), a leading cause of blindness. The company offers the AdaptDx, a fully automated dark adaptometer designed to aid eye care professionals in detecting and tracking AMD at its earliest stages, potentially up to three years before it becomes visible. This early detection capability allows for timely intervention, which can help prevent vision loss. MacuLogix markets its products through distributors in the United States and internationally, as well as online, to ensure accessibility for healthcare providers. Founded in 2008 and based in Harrisburg, Pennsylvania, MacuLogix is committed to leveraging the science of dark adaptation to combat preventable blindness associated with AMD.

New Signature is a cloud-first, full-service Microsoft technology partner that provides comprehensive technology services to businesses of all sizes and industries. The company focuses on solving complex business challenges by leveraging Microsoft solutions, employing a process-driven approach that ensures consistent success for its clients. New Signature assists organizations in making informed investment decisions through thorough economic analysis, highlighting the value of Microsoft offerings. Their expertise encompasses planning, designing, deploying, customizing, managing, and supporting Microsoft services, with an emphasis on delivering maximum return on investment. Additionally, the company offers tailored user adoption and learning solutions aimed at enhancing the proficiency of both business users and IT professionals.

Ontrak is an AI-powered and technology-enabled behavioral healthcare company focused on improving health outcomes for individuals with behavioral conditions that lead to chronic medical issues. The company offers specialized health management services through a network of licensed providers, utilizing claim-based analytics and predictive modeling to deliver personalized care programs. Ontrak's integrated solutions combine medical and psychosocial interventions with long-term care coaching and online tools to support members in their recovery from substance dependence and other behavioral health challenges.

Since 2003, we help companies driving digital innovation, with disruptive methodologies. We design new brands, new services and new products, in collaboration with our clients and their partners. We assist large groups, start-ups and SMEs in the conduct of disruption (Disrupt), of digital experience design (Design), and the conduct of growth (Scale). Our approach is different from a digital agency: we are structured as a consultancy, with concrete execution abilities in design and in marketing.

Audacy is a space communications service provider enabling continuous satellite and launch vehicle connectivity from the launchpad to the Moon. Its mission is to deliver anytime, highly operable connectivity that advances humankind to an unparalleled age of space exploration and discovery. The company was founded in 2015 and headquartered in Mountain View, California.

IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

Conventus Orthopaedics provides a range of orthopedic and sports medicine services. The physicians specialize in orthopedic surgery, reconstructive surgery, spine surgery, joint replacement, sports medicine, physical therapy, and operative care of fractures, arthritis, strains, sprains, and sports-related injuries. Conventus was formed by a team of medical professionals with the sole purpose of creating less invasive ways to treat challenging periarticular fractures. By leveraging advanced nitinol technology, the Conventus team has developed a platform technology that provides robust fixation and creates reliable repairs. The company was incorporated in 2009 and is based in Maple Grove, Minnesota.

Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing proprietary therapeutics for chronic diseases through its innovative ProNeura long-term drug delivery platform. The company's key product, Probuphine, is the first slow-release implant formulation of buprenorphine, designed to provide stable medication levels for up to six months, thereby enhancing patient compliance in the treatment of opioid dependence. Titan also develops ProNeura-Ropinirole, an implant for delivering ropinirole to treat Parkinson's disease, and a similar implant for managing hypothyroidism. The ProNeura technology holds promise for addressing various chronic conditions by ensuring consistent drug delivery, which can improve patient outcomes. In December 2012, Titan entered a licensing agreement granting Braeburn Pharmaceuticals exclusive commercialization rights to Probuphine in the U.S. and Canada, receiving significant financial incentives tied to regulatory approvals and sales milestones. Additionally, Titan receives royalties from the sales of Fanapt, an atypical antipsychotic, further supporting its development efforts.

PebblePost, Inc. is a New York-based company that operates a digital-to-direct mail marketing platform. Established in 2014, PebblePost specializes in transforming online consumer behavior into targeted direct mail campaigns. By leveraging online interest and intent data, the company sends personalized direct mail that aims to activate purchasing decisions and enhance conversion rates. PebblePost is known for its innovation in Programmatic Direct Mail, which utilizes advanced targeting and algorithmic optimization techniques. The platform integrates various marketing functions, including segmentation, campaign management, production, analytics, and optimization, allowing brands to effectively engage consumers through tailored media impressions delivered to their homes.

IgnitionOne, Inc. is a New York-based company that specializes in cloud-based digital marketing software solutions for online marketers globally. Founded in 2003 and originally named SearchIgnite, Inc., the company changed its name in 2011 to reflect its expanded focus on customer intelligence. IgnitionOne offers a comprehensive suite of tools, including a Marketing Hub Data Management Platform that consolidates customer information across various channels, a Digital Marketing Dashboard for monitoring campaigns, and analytics solutions for enhanced marketing insights. Additionally, the company provides website personalization and email optimization services, enabling marketers to engage effectively with their most valuable customers. By leveraging customer data from diverse systems, IgnitionOne's platform facilitates intelligent audience targeting and real-time optimization, empowering businesses to make informed marketing decisions.

Strongbridge Biopharma plc is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases with significant unmet medical needs. The company’s primary focus is on rare endocrine disorders, exemplified by its product candidates, Recorlev, a cortisol synthesis inhibitor currently in Phase III trials for endogenous Cushing's syndrome, and Veldoreotide, a somatostatin analog that has completed Phase II trials for acromegaly. Strongbridge also offers Keveyis, an oral carbonic anhydrase inhibitor approved for treating specific forms of periodic paralysis in the United States. Founded in 1996 and headquartered in Trevose, Pennsylvania, the company aims to leverage a concentrated prescriber base for its products and plans to utilize a targeted sales force for marketing in the U.S., European Union, and other key markets. Additionally, Strongbridge seeks to enhance its portfolio through the in-licensing or acquisition of complementary products that align with its focus on rare endocrine conditions.

Receptiv is a mobile video advertising platform that enhances ad performance by connecting brands with receptive users during significant moments. Founded in 2011 as MediaBrix, the company rebranded to Receptiv in March 2017 and is headquartered in New York City. It offers solutions through both programmatic and managed services, focusing on creating contextual brand engagements. Receptiv utilizes its first-party data management platform, Motiv, which leverages insights from 150 million device IDs to combine emotional targeting with audience intelligence. The platform operates across more than 1,300 premium apps, generating 500 million key advertising moments monthly. Receptiv's client roster includes major brands such as Mars, Coca-Cola, and Microsoft. As of May 2018, it functions as a subsidiary of Verve Wireless, Inc., and is recognized for its innovative approach in the digital advertising space.

ScoreBig, Inc. operates an online marketplace that focuses on providing consumers with discounted tickets to live events, including sports games, concerts, and theater performances. Established in 2009 and based in Hollywood, California, the company offers a unique opaque sales channel, allowing fans to save up to 60% on ticket purchases. By selling a limited number of tickets per event, ScoreBig helps venue operators and sports teams manage unsold inventory without undermining their regular pricing strategies. This approach enables consumers to access a wide range of tickets, from premium seats to more affordable options, while also supporting event organizers in maximizing revenue. As of November 2016, ScoreBig operates as a subsidiary of Ticket Software, LLC.

Avalanche Technology, Inc. is a technology company based in Fremont, California, specializing in the development and marketing of non-volatile spin transfer torque magnetic random access memory (MRAM) devices. Founded in 2006, the company provides innovative memory solutions aimed at enhancing speed, endurance, and energy efficiency across a range of applications, including mobile devices, the Internet of Things, enterprise storage, computing, networking, telecommunications, and automotive industries. Avalanche Technology's products serve as alternatives to traditional static random access memory, flash, and read-only memory, utilizing perpendicular magnetic tunnel junction technology to deliver low power consumption. With a strong focus on research and development, the company holds a substantial portfolio of over 200 patents related to its cell, circuit, process, and system innovations, positioning itself as a leader in the evolving landscape of memory technology.

Nomi is an omni-channel marketing platform designed to enhance customer engagement for retailers. By analyzing and optimizing the return on investment from offline marketing and store operations, Nomi quantifies the effectiveness of marketing campaigns in driving foot traffic and assesses customer lifetime value. The platform helps retailers evaluate how well stores convert visitors into buyers, identify underperforming staff, and measure the impact of training and management investments on customer behavior. Nomi offers a comprehensive view of the customer conversion funnel, enabling retailers to predict store performance and diagnose operational issues proactively. Founded in September 2012 by Marc Ferrentino, Corey Capasso, Wesley Barrow, Peter Quintas, and Robert Balousek, the company is headquartered in New York, United States.

Digital Signal, founded in 2001 and based in Chantilly, Virginia, specializes in three-dimensional long-range facial recognition technology tailored for both government and commercial clients. The company develops LIDAR-based biometric solutions designed to identify non-cooperative individuals and detect faces in crowded environments. Its technology offers comprehensive identity intelligence, encompassing enrollment, monitoring, and identity analytics. By leveraging the advanced capabilities of 3D facial scanning, Digital Signal's solutions can accurately identify subjects in motion or at various angles, even when wearing sunglasses, which enhances surveillance efficiency and effectiveness. The company also provides customized applications to meet specific customer requirements.

New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company focused on developing proprietary prescription medications that leverage currently marketed drugs and generally recognized as safe (GRAS) active pharmaceutical ingredients for therapeutic applications with substantial market potential. The company is advancing a product pipeline that features innovative, oral, controlled-release technologies, enhancing dosing accuracy, safety, efficacy, and patient convenience. NHP's research is supported by intellectual property licensed from Yale University, allowing for the development of new therapeutic indications using established compounds.

Bridge2 Solutions, Inc. operates a marketing solutions platform that facilitates engagement and loyalty for financial institutions, retailers, and Fortune 500 companies. Founded in 2006 and headquartered in Alpharetta, Georgia, with additional locations in Scottsdale, Arizona, and Chennai, India, the company connects consumers with retail partners and loyalty programs through various offerings, including merchandise, travel, and entertainment. Its cloud-based platform provides software-based redemption services, allowing loyalty and rewards program sponsors to seamlessly interact with trusted retail and travel brands without the need for physical inventory. In addition to its core services, Bridge2 Solutions offers comprehensive customer and account support, as well as managed services such as database management and network monitoring, ensuring efficient operations for its clients.

Medsphere Systems Corporation is a healthcare information technology company based in Carlsbad, California, founded in 2002. It specializes in providing open-source software solutions, notably through its OpenVista platform, which offers a comprehensive electronic health record system. This platform supports various healthcare functions, including clinical, financial, patient accounting, laboratory, pharmacy, radiology, and nutrition services. Medsphere also delivers a range of professional services, such as implementation, training, support, and system integration to enhance operational efficiency in hospitals, clinics, and integrated delivery networks. The company's solutions are designed to streamline clinical workflows and improve patient care while ensuring interoperability across different healthcare systems. Medsphere serves a diverse clientele, including critical access hospitals, acute care facilities, behavioral health centers, and government entities.

SilkRoad Technology, Inc. provides cloud-based talent management solutions for organizations in the United States and internationally. Founded in 2003 and headquartered in Chicago, Illinois, the company offers a comprehensive suite of tools designed to enhance various aspects of human resources. Key offerings include SilkRoad Suite Start for talent acquisition, SilkRoad Recruiting for utilizing social channels in hiring, and SilkRoad Onboarding for employee integration. Additionally, it provides SilkRoad Performance for managing employee performance, SilkRoad Learning for social learning and content management, and SilkRoad HRMS for maintaining accurate employee records. The company serves diverse sectors such as financial services, healthcare, higher education, manufacturing, professional services, and retail. SilkRoad Technology also offers pre-sales consultation, implementation support, and training services to ensure clients effectively leverage their HR solutions. With locations across North America, Europe, Asia, and Australia, SilkRoad Technology focuses on delivering personalized experiences that enhance employee engagement and contribute to improved business outcomes.

SavingStar, Inc. is an online grocery rewards platform that offers cash back on grocery and online shopping purchases. Founded in 2010 and based in Waltham, Massachusetts, the company allows users to redeem offers by linking them to their supermarket and drugstore loyalty cards or by submitting a receipt image. Shoppers earn cash back on specific item-level purchases, with the value automatically credited to their SavingStar or partner accounts. The platform also supports double cash back at various online retailers, including popular websites. Additionally, brands can utilize the platform to run promotions, incentivizing shoppers to buy specific products or engage with content. SavingStar was formerly known as SaveWave Inc. and adopted its current name in February 2011. It operates as a subsidiary of Quotient Technology Inc.

ScoreBig, Inc. operates an online marketplace that focuses on providing consumers with discounted tickets to live events, including sports games, concerts, and theater performances. Established in 2009 and based in Hollywood, California, the company offers a unique opaque sales channel, allowing fans to save up to 60% on ticket purchases. By selling a limited number of tickets per event, ScoreBig helps venue operators and sports teams manage unsold inventory without undermining their regular pricing strategies. This approach enables consumers to access a wide range of tickets, from premium seats to more affordable options, while also supporting event organizers in maximizing revenue. As of November 2016, ScoreBig operates as a subsidiary of Ticket Software, LLC.

NinePoint Medical, Inc. is a medical device company based in Bedford, Massachusetts, that specializes in optical coherence tomography (OCT) imaging systems for assessing human tissue microstructure. The company's flagship product, the NvisionVLE Imaging System, provides real-time volumetric images of the esophagus and bile duct, enabling healthcare professionals across various specialties, including gastroenterology and pulmonology, to conduct advanced imaging procedures. This technology allows for high-resolution, cross-sectional views that facilitate accurate diagnoses and effective therapies during medical procedures. NinePoint aims to enhance the efficiency of patient care by integrating access to imaging, diagnosis, and treatment in a single procedure, ultimately improving patient outcomes and reducing healthcare costs. The company markets its products through distributors both domestically and internationally. Established in 2008, NinePoint Medical was formerly known as Convergence Devices, Inc. and underwent a name change in 2009.

Palatin Technologies is a biopharmaceutical company focused on developing targeted, receptor-specific peptide therapeutics to address significant unmet medical needs. Based in Cranbury, New Jersey, the company’s lead product is Vyleesi, a melanocortin receptor agonist designed for the treatment of premenopausal women with hypoactive sexual desire disorder. Palatin is also advancing several other candidates, including oral PL8177, which targets inflammatory bowel diseases, and systemic PL8177, aimed at treating non-infectious uveitis and COVID-19. Additionally, the company is developing PL9643 for anti-inflammatory ocular conditions like dry eye disease, as well as PL3994 and PL5028, which target cardiovascular and fibrotic diseases. Their research emphasizes the modulation of melanocortin and natriuretic peptide receptor systems to resolve inflammation and facilitate tissue healing, with applications extending to various conditions, including obesity, erectile dysfunction, and pulmonary diseases.

Interleukin Genetics, Inc. is a company specializing in personalized health through the development of genetic tests aimed at enhancing individual wellness. The organization focuses on two primary areas: the provision of genetic test products for personal health improvement and research and development efforts that create tests linked to partners’ products for medical and dental markets. Their genetic testing technology provides clear insights into wellness, offering personalized guidance on diet and exercise choices, which empowers individuals to take proactive steps in managing their health. Through partnerships and direct sales channels, Interleukin Genetics aims to contribute to the growing personalized health market by enabling individuals to make informed decisions about their health and wellness.

ZetrOZ, LLC is a manufacturer based in Trumbull, Connecticut, specializing in advanced ultrasound technology. Founded in 2009, the company focuses on developing non-invasive medical devices aimed at tissue healing and pain relief for chronic musculoskeletal conditions. ZetrOZ offers a range of products, including the UltrOZ Elite therapeutic systems, wearable veterinary ultrasound systems, and high intensity focused ultrasound systems tailored for biomedical research and industrial applications. Their product lineup also features low-profile ultrasound transducers for therapeutic and diagnostic uses, as well as a variety of applications in industrial monitoring and aquatic environments. The company's innovative generator technology enhances efficiency, portability, and cost-effectiveness, making ultrasound systems more accessible for therapeutic uses such as wound care, surgical procedures, and aesthetic treatments.

InVisage Technologies, Inc. is a fabless semiconductor company headquartered in Menlo Park, California, specializing in the development of QuantumFilm-based image sensors. Founded in 2005, the company focuses on producing advanced image sensors that capture high-fidelity and high-resolution images for various handheld devices, including camera phones and digital cameras. InVisage's technology is designed to absorb the full spectrum of light visible to the human eye, resulting in superior image quality. Its products have applications beyond mobile devices, extending to fields such as security and surveillance, automotive imaging, military, and medical imaging. As of November 2017, InVisage operates as a subsidiary of Apple Inc.

Argos Therapeutics, Inc. was a biotechnology company based in Durham, North Carolina, focused on developing personalized immunotherapies for cancer, infectious diseases, and autoimmune disorders. It utilized its proprietary Arcelis technology platform to create individualized treatments, including rocapuldencel-T, which was undergoing Phase III clinical trials for metastatic renal cell carcinoma, and AGS-004, in Phase II trials for human immunodeficiency virus. The company's product pipeline also included therapies aimed at transplant rejection and autoimmune conditions. Founded in 1997 and originally named Merix Bioscience, Argos Therapeutics aimed to address significant unmet medical needs in the field of immuno-oncology. However, on September 24, 2019, the company filed for Chapter 7 bankruptcy, leading to its cessation of operations.

IntegenX, Inc. specializes in developing human DNA identification solutions, particularly for forensics and law enforcement. The company utilizes advanced technology platforms that combine fluidics, optics, and biochemistry to create automated sample-to-answer products for DNA-based identity testing. Among its offerings are the RapidHIT System, which automates the production of standardized DNA profiles from various human samples, and the RapidHIT GlobalFiler Express Kit, designed for direct processing of crime scene samples. Additionally, IntegenX provides systems like the Apollo 100 and Apollo 200 for DNA sequencing and sample preparation. Founded in 2003 and based in Pleasanton, California, IntegenX was previously known as Microchip Biotechnologies, Inc. and became a subsidiary of Thermo Fisher Scientific Inc. in 2018. The company's products are distributed internationally across various countries, enhancing their reach in the market for reliable DNA identification solutions.

SpringCM Inc. is a cloud-based document and contract management platform based in Chicago, Illinois, founded in 2005. The company provides solutions that streamline the contract lifecycle, encompassing contract creation, negotiation, approval, signature, archiving, and renewal. Additionally, it offers a digital asset management system that automates processes related to content management, sharing, and collaboration. SpringCM's software enables organizations to efficiently store, organize, and search for documents while facilitating collaboration both internally and externally. The platform is delivered as Software-as-a-Service and includes a mobile application for enhanced accessibility. SpringCM serves various sectors, including legal, IT, operations, sales, human resources, public sector, procurement, and finance. The company also provides consulting, training, and support services to its clients. In 2018, SpringCM became a subsidiary of DocuSign, Inc., and has established a strategic partnership with Salesforce to enhance its service offerings.

Founded in 1999, Mblox is a leading provider of mobile messaging and payment solutions, specializing in Application-to-Person communication. The company has established over 100 direct relationships with mobile carriers worldwide, making it a trusted partner for businesses needing reliable mobile messaging services. Mblox processes approximately 7 billion messages annually for over 4,000 clients, ranging from small startups to large multinational corporations. Their cloud-based platform is designed to meet the diverse needs of various industries, including financial services, government, transportation, logistics, retail, and advertising. Mblox is committed to customer service, offering 24/7 email support through an in-house team of experts, along with tailored support packages to accommodate different business requirements.

GenePeeks, Inc. is a genetic information company headquartered in New York, New York, that focuses on reducing the risk of heritable diseases through innovative technology. Incorporated in 2009, the company has developed a proprietary software platform that digitally combines the DNA of prospective parents to simulate genetic recombination and reduction. This process generates a comprehensive analysis of potential future children’s genetic profiles, identifying disease risks that existing pre-conception screening methods may overlook. By utilizing Next-Gen sequencing data, GenePeeks creates tens of thousands of virtual genomes, enabling healthcare providers to assess high-risk genetic matches and enhance their understanding of clinically relevant genotypes and variants. The company's mission is to help families safeguard the health of future generations by providing deeper genetic insights.

Social Intelligence Corp. specializes in providing social media data and analytics to commercial and government organizations. Based in Santa Barbara, California, the company offers software-as-a-service tools that include predictive scoring algorithms and extensive data resources. Their products are designed for employment background screenings, insurance claims investigations, corporate due diligence, and various government services. Social Intelligence is committed to adhering to the Fair Credit Reporting Act and complies with federal and state regulations to ensure responsible use of publicly available online information. The company emphasizes the importance of privacy, productivity, and community involvement, and is supported by a diverse team with extensive experience in software, insurance, government services, and employment sectors.

AccuVein Inc. is a manufacturer of vein visualization solutions aimed at enhancing clinical care for healthcare professionals. Founded in 2006 and based in Medford, New York, the company specializes in portable, non-contact devices that enable practitioners to visualize peripheral veins on a patient's skin. Its flagship product, the AV400, utilizes proprietary technology to assist in locating veins for various medical procedures, including IV access, blood draws, and cosmetic injections. AccuVein also offers a range of products, including hands-free and wheeled solutions, to cater to different medical settings such as surgery centers, imaging centers, and long-term care facilities. The company's products are distributed through a network of sales representatives and distributors both domestically and internationally.

Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.

Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. Complete loss of vision or vision impairment currently affects 3.3 million people over the age of 40 in the United States, with the most common diseases including age-related macular degeneration (AMD), glaucoma, cataract and diabetic retinopathy. With the continued aging of the population, the National Eye Institute projects that this number will grow to 5.5 million people by the year 2020.

Overture Networks, Inc. specializes in providing virtualization solutions and high-speed carrier Ethernet edge and aggregation services tailored for carrier-class service providers. Founded in 2000 and headquartered in Morrisville, North Carolina, with additional development offices in Westford, Massachusetts, and Bangalore, India, the company offers a diverse range of products. These include the Overture Orchestrator for cost-effective service delivery, Overture Analytics for actionable intelligence, and various Ethernet access devices that facilitate the transition from traditional TDM infrastructure to modern Ethernet networks. Key offerings also encompass the Overture 65vSE, a carrier-class server, and platforms like the Overture 6500 for performance-assured services across multiple transport mediums. By integrating packet-switched and circuit-switched technologies, Overture Networks delivers adaptable and cost-efficient solutions that cater to various service provider requirements.

Valore is a company dedicated to transforming the textbook industry by addressing its inefficiencies and enhancing access to affordable educational resources. Based in San Diego, Valore operates ValoreBooks.com, a marketplace where college students can buy and sell textbooks at significantly lower prices than those offered by campus bookstores. The platform features a vast selection of titles sourced from over 14,000 booksellers nationwide, often priced up to 90 percent below list price. Valore is recognized for its commitment to providing cost-effective solutions for students while maintaining a high standard of customer service, as evidenced by accolades from the Better Business Bureau. Through these efforts, Valore aims to improve the overall educational experience for students, professors, and educational institutions.

Radisphere National Radiology Group, Inc. offers comprehensive radiology delivery solutions tailored for hospitals and health systems. The company specializes in cloud-based technology solutions, including RadVision and RadPerform, which enhance performance transparency, facilitate benchmarking, and optimize clinical operations. Radisphere's services include on-site radiologist staffing, remote sub-specialist interpretations, and 24/7 care management, allowing health systems to streamline their radiology processes. By centralizing radiology management, Radisphere enables clients to achieve higher quality care while reducing costs and clinical variation. With a client base exceeding 100 across 28 states, Radisphere is committed to transforming radiology practices through measurable performance standards and accountability for diagnostic accuracy and patient care. Founded in 2001 and based in Beachwood, Ohio, Radisphere operates as a subsidiary of Envision Healthcare Corporation.

Enphase Energy, Inc. is a global energy technology company headquartered in Fremont, California, specializing in home energy solutions for the solar photovoltaic industry. Founded in 2006, the company designs, develops, manufactures, and sells innovative products including semiconductor-based microinverters, which convert energy at the individual solar module level, and energy storage systems. Enphase Energy's offerings are complemented by its proprietary networking and software technologies that provide advanced energy monitoring and control services. The company serves a diverse customer base that includes solar distributors, large installers, original equipment manufacturers, and homeowners, facilitating access to its solutions through various channels, including an online store. Additionally, Enphase provides training resources for solar and storage installers and system owners through its Enphase University. By integrating solar generation, storage, and communication on a single platform, Enphase aims to enhance the performance, reliability, and intelligence of solar energy systems, ultimately empowering users to achieve a zero-energy footprint.

Grab Media is a prominent video distribution company that specializes in connecting premium video content with a diverse array of professional sources and well-known advertisers. The company offers digital advertising and video syndication solutions, enabling marketers to effectively reach large, engaged audiences. By hosting, distributing, and monetizing streaming media, Grab Media allows brands to concentrate on promoting their messages while ensuring that their content reaches the right viewers.

Tagged.com was launched in 2004, and is an explosively growing social-networking portal developed specifically for teens aged 13 through 19. Emerging as the premier brand in the lucrative teen demographic, Tagged.com is rapidly becoming the number one teen site on the web.

Revance Therapeutics is a biotechnology company that focuses on developing, manufacturing, and commercializing neuromodulators for aesthetic and therapeutic applications. Its primary product, DaxibotulinumtoxinA for injection (DAXI), is undergoing various clinical trials for treating conditions such as glabellar lines, cervical dystonia, adult upper limb spasticity, and plantar fasciitis, while also being explored for chronic migraine treatment. Additionally, Revance is developing topical formulations of DAXI and a biosimilar to BOTOX. The company has established collaborations for the development and commercialization of these products. Revance also offers a portfolio of aesthetic products, including the RHA Collection of dermal fillers and the HintMD platform. Founded in 1999 and headquartered in Newark, California, Revance Therapeutics was previously known as Essentia Biosystems.

Ambit Biosciences is a privately-held biopharmaceutical company that specializes in the discovery and development of small molecule kinase inhibitors aimed at treating cancer and inflammatory diseases. The company's lead compound, AC220, is a selective and orally bioavailable inhibitor of FMS-like tyrosine kinase-3 (FLT3), currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various therapeutic areas. In addition to AC220, Ambit's clinical pipeline features AC480, a pan-HER inhibitor, and AC430, an oral inhibitor of JAK2. Furthermore, the company has several preclinical candidates, including CEP-32496, a BRAF inhibitor that is licensed to Cephalon. Through its innovative approach, Ambit aims to enhance treatment outcomes for cancer patients.

COPAN Systems, Inc. is a technology company based in Longmont, Colorado, founded in 2002. The company specializes in providing a comprehensive range of idle disk storage solutions designed to maximize the value of long-term persistent data. Its product offerings include virtual tape libraries for backup and disaster recovery, as well as archiving solutions that enable the retention and retrieval of digital assets at the file level. In addition to these core products, COPAN Systems delivers services related to data protection, tiered storage, and efficient power and cooling management. The company's diverse clientele spans multiple sectors, including education, finance, government, healthcare, technology, media, and service providers, reflecting its broad applicability in the data storage market.

Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

SparkCharge, Inc. is an automotive company that designs and manufactures portable charging stations for electric vehicles. Founded in 2014 and based in Boston, Massachusetts, SparkCharge aims to address the limitations of traditional charging infrastructure. Its innovative products are characterized by fast charging capabilities and a modular design, allowing users to charge their electric vehicles conveniently and without the need for a fixed power source. This mobility enhances the overall electric vehicle ownership experience by enabling drivers to charge their cars wherever they go, making electric vehicle charging more accessible and practical.